Global Drug Safety and Pharmacovigilance (PV) Software Market Research Report 2023

The global Drug Safety and Pharmacovigilance (PV) Software market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Drug Safety and Pharmacovigilance (PV) Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Drug Safety and Pharmacovigilance (PV) Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Drug Safety and Pharmacovigilance (PV) Software in Pharma and Biotech Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Drug Safety and Pharmacovigilance (PV) Software include ArisGlobal (US), Ennov Solutions Inc. (US), EXTEDO GmbH (US), Online Business Applications, Inc. (US), Oracle Corporation (US), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (US) and United BioSource Corporation (US), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Drug Safety and Pharmacovigilance (PV) Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety and Pharmacovigilance (PV) Software.

The Drug Safety and Pharmacovigilance (PV) Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Safety and Pharmacovigilance (PV) Software market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Safety and Pharmacovigilance (PV) Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 On-Premises

1.2.3 Cloud-Based

1.3 Market by Application

1.3.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Pharma and Biotech Companies

1.3.3 Contract Research Organizations (CROs)

1.3.4 Business Process Outsourcing (BPO) Firms

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Perspective (2018-2029)

2.2 Drug Safety and Pharmacovigilance (PV) Software Growth Trends by Region

2.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Region (2018-2023)

2.2.3 Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Region (2024-2029)

2.3 Drug Safety and Pharmacovigilance (PV) Software Market Dynamics

2.3.1 Drug Safety and Pharmacovigilance (PV) Software Industry Trends

2.3.2 Drug Safety and Pharmacovigilance (PV) Software Market Drivers

2.3.3 Drug Safety and Pharmacovigilance (PV) Software Market Challenges

2.3.4 Drug Safety and Pharmacovigilance (PV) Software Market Restraints

3.1 Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Revenue

3.1.1 Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Revenue (2018-2023)

3.1.2 Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Players (2018-2023)

3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance (PV) Software Revenue

3.4 Global Drug Safety and Pharmacovigilance (PV) Software Market Concentration Ratio

3.4.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance (PV) Software Revenue in 2022

3.5 Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Area Served

3.6 Key Players Drug Safety and Pharmacovigilance (PV) Software Product Solution and Service

3.7 Date of Enter into Drug Safety and Pharmacovigilance (PV) Software Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Type (2018-2023)

4.2 Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Type (2024-2029)

5.1 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Application (2018-2023)

5.2 Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Application (2024-2029)

6.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size (2018-2029)

6.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023)

6.4 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size (2018-2029)

7.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023)

7.4 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size (2018-2029)

8.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2018-2023)

8.4 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size (2018-2029)

9.2 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023)

9.4 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size (2018-2029)

10.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023)

10.4 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 ArisGlobal (US)

11.1.1 ArisGlobal (US) Company Detail

11.1.2 ArisGlobal (US) Business Overview

11.1.3 ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.1.4 ArisGlobal (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.1.5 ArisGlobal (US) Recent Development

11.2 Ennov Solutions Inc. (US)

11.2.1 Ennov Solutions Inc. (US) Company Detail

11.2.2 Ennov Solutions Inc. (US) Business Overview

11.2.3 Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.2.4 Ennov Solutions Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.2.5 Ennov Solutions Inc. (US) Recent Development

11.3 EXTEDO GmbH (US)

11.3.1 EXTEDO GmbH (US) Company Detail

11.3.2 EXTEDO GmbH (US) Business Overview

11.3.3 EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.3.4 EXTEDO GmbH (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.3.5 EXTEDO GmbH (US) Recent Development

11.4 Online Business Applications, Inc. (US)

11.4.1 Online Business Applications, Inc. (US) Company Detail

11.4.2 Online Business Applications, Inc. (US) Business Overview

11.4.3 Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.4.4 Online Business Applications, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.4.5 Online Business Applications, Inc. (US) Recent Development

11.5 Oracle Corporation (US)

11.5.1 Oracle Corporation (US) Company Detail

11.5.2 Oracle Corporation (US) Business Overview

11.5.3 Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.5.4 Oracle Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.5.5 Oracle Corporation (US) Recent Development

11.6 Sarjen Systems Pvt. Ltd (India)

11.6.1 Sarjen Systems Pvt. Ltd (India) Company Detail

11.6.2 Sarjen Systems Pvt. Ltd (India) Business Overview

11.6.3 Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.6.4 Sarjen Systems Pvt. Ltd (India) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.6.5 Sarjen Systems Pvt. Ltd (India) Recent Development

11.7 Sparta Systems, Inc. (US)

11.7.1 Sparta Systems, Inc. (US) Company Detail

11.7.2 Sparta Systems, Inc. (US) Business Overview

11.7.3 Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.7.4 Sparta Systems, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.7.5 Sparta Systems, Inc. (US) Recent Development

11.8 United BioSource Corporation (US)

11.8.1 United BioSource Corporation (US) Company Detail

11.8.2 United BioSource Corporation (US) Business Overview

11.8.3 United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Introduction

11.8.4 United BioSource Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

11.8.5 United BioSource Corporation (US) Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of On-Premises

    Table 3. Key Players of Cloud-Based

    Table 4. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2018-2023)

    Table 8. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2024-2029)

    Table 10. Drug Safety and Pharmacovigilance (PV) Software Market Trends

    Table 11. Drug Safety and Pharmacovigilance (PV) Software Market Drivers

    Table 12. Drug Safety and Pharmacovigilance (PV) Software Market Challenges

    Table 13. Drug Safety and Pharmacovigilance (PV) Software Market Restraints

    Table 14. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Players (2018-2023)

    Table 16. Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance (PV) Software as of 2022)

    Table 17. Ranking of Global Top Drug Safety and Pharmacovigilance (PV) Software Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Drug Safety and Pharmacovigilance (PV) Software Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Drug Safety and Pharmacovigilance (PV) Software Product Solution and Service

    Table 21. Date of Enter into Drug Safety and Pharmacovigilance (PV) Software Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2018-2023)

    Table 25. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2024-2029)

    Table 27. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Application (2018-2023)

    Table 29. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Application (2024-2029)

    Table 31. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2024-2029) & (US$ Million)

    Table 46. ArisGlobal (US) Company Detail

    Table 47. ArisGlobal (US) Business Overview

    Table 48. ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 49. ArisGlobal (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 50. ArisGlobal (US) Recent Development

    Table 51. Ennov Solutions Inc. (US) Company Detail

    Table 52. Ennov Solutions Inc. (US) Business Overview

    Table 53. Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 54. Ennov Solutions Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 55. Ennov Solutions Inc. (US) Recent Development

    Table 56. EXTEDO GmbH (US) Company Detail

    Table 57. EXTEDO GmbH (US) Business Overview

    Table 58. EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 59. EXTEDO GmbH (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 60. EXTEDO GmbH (US) Recent Development

    Table 61. Online Business Applications, Inc. (US) Company Detail

    Table 62. Online Business Applications, Inc. (US) Business Overview

    Table 63. Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 64. Online Business Applications, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 65. Online Business Applications, Inc. (US) Recent Development

    Table 66. Oracle Corporation (US) Company Detail

    Table 67. Oracle Corporation (US) Business Overview

    Table 68. Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 69. Oracle Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 70. Oracle Corporation (US) Recent Development

    Table 71. Sarjen Systems Pvt. Ltd (India) Company Detail

    Table 72. Sarjen Systems Pvt. Ltd (India) Business Overview

    Table 73. Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 74. Sarjen Systems Pvt. Ltd (India) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 75. Sarjen Systems Pvt. Ltd (India) Recent Development

    Table 76. Sparta Systems, Inc. (US) Company Detail

    Table 77. Sparta Systems, Inc. (US) Business Overview

    Table 78. Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 79. Sparta Systems, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 80. Sparta Systems, Inc. (US) Recent Development

    Table 81. United BioSource Corporation (US) Company Detail

    Table 82. United BioSource Corporation (US) Business Overview

    Table 83. United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Product

    Table 84. United BioSource Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023) & (US$ Million)

    Table 85. United BioSource Corporation (US) Recent Development

    Table 86. Research Programs/Design for This Report

    Table 87. Key Data Information from Secondary Sources

    Table 88. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Type: 2022 VS 2029

    Figure 3. On-Premises Features

    Figure 4. Cloud-Based Features

    Figure 5. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Application: 2022 VS 2029

    Figure 7. Pharma and Biotech Companies Case Studies

    Figure 8. Contract Research Organizations (CROs) Case Studies

    Figure 9. Business Process Outsourcing (BPO) Firms Case Studies

    Figure 10. Other Case Studies

    Figure 11. Drug Safety and Pharmacovigilance (PV) Software Report Years Considered

    Figure 12. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Drug Safety and Pharmacovigilance (PV) Software Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Region: 2022 VS 2029

    Figure 15. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Players in 2022

    Figure 16. Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance (PV) Software as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Drug Safety and Pharmacovigilance (PV) Software Revenue in 2022

    Figure 18. North America Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2018-2029)

    Figure 20. United States Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2018-2029)

    Figure 24. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2018-2029)

    Figure 32. China Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2018-2029)

    Figure 40. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2018-2029)

    Figure 44. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. ArisGlobal (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 47. Ennov Solutions Inc. (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 48. EXTEDO GmbH (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 49. Online Business Applications, Inc. (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 50. Oracle Corporation (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 51. Sarjen Systems Pvt. Ltd (India) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 52. Sparta Systems, Inc. (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 53. United BioSource Corporation (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed